{"id":"randomization-between-two-established-chemotherapies","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL279814","moleculeType":"Small molecule","molecularWeight":"428.47"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This entry describes a study design (randomization between two chemotherapies) rather than a discrete pharmaceutical product. The specific mechanisms depend on which two chemotherapy agents are being compared in the trial. Without identification of the particular chemotherapies involved, a mechanistic description cannot be accurately provided.","oneSentence":"This is a randomized clinical trial comparing two established chemotherapy regimens rather than a single drug entity.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:03:46.509Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07367711","phase":"","title":"The Influence of Chemotherapy on Position Sense","status":"NOT_YET_RECRUITING","sponsor":"KU Leuven","startDate":"2026-02","conditions":"CIPN - Chemotherapy-Induced Peripheral Neuropathy, Chemotherapy-Induced Peripheral Neuropathy, Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer","enrollment":145},{"nctId":"NCT05376709","phase":"NA","title":"A Mixed Methods Study of Nutrition Practice in Cancer Care on Non-Hodgkin Lymphoma Population","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2020-09-01","conditions":"Lymphoma, B-Cell","enrollment":200},{"nctId":"NCT00039741","phase":"PHASE2, PHASE3","title":"Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2002-08","conditions":"HIV Infections","enrollment":266},{"nctId":"NCT02586896","phase":"NA","title":"Comparing Interventions for Opioid Dependent Patients Presenting in Medical Emergency Departments","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2016-03","conditions":"Opioid Dependence","enrollment":300},{"nctId":"NCT00180167","phase":"PHASE4","title":"Therapy of Acute Myeloid Leukemia in Patients Over the Age of 60 : DA Versus Mitoxantrone With Intermittent AraC","status":"COMPLETED","sponsor":"Technische Universität Dresden","startDate":"2005-01","conditions":"Leukemia, Nonlymphocytic, Acute","enrollment":492}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"randomization between two established Chemotherapies","genericName":"randomization between two established Chemotherapies","companyName":"Technische Universität Dresden","companyId":"technische-universit-t-dresden","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}